Cargando…
Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction”
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577604/ https://www.ncbi.nlm.nih.gov/pubmed/25652635 http://dx.doi.org/10.4103/1008-682X.148069 |
_version_ | 1782390991646359552 |
---|---|
author | Cao, De-Hong Liu, Liang-Ren Wei, Qiang |
author_facet | Cao, De-Hong Liu, Liang-Ren Wei, Qiang |
author_sort | Cao, De-Hong |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4577604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45776042015-09-23 Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction” Cao, De-Hong Liu, Liang-Ren Wei, Qiang Asian J Androl Letter to the Editor Medknow Publications & Media Pvt Ltd 2015 2015-01-16 /pmc/articles/PMC4577604/ /pubmed/25652635 http://dx.doi.org/10.4103/1008-682X.148069 Text en Copyright: © Asian Journal of Andrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms |
spellingShingle | Letter to the Editor Cao, De-Hong Liu, Liang-Ren Wei, Qiang Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction” |
title | Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction” |
title_full | Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction” |
title_fullStr | Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction” |
title_full_unstemmed | Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction” |
title_short | Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction” |
title_sort | commentary on – “comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577604/ https://www.ncbi.nlm.nih.gov/pubmed/25652635 http://dx.doi.org/10.4103/1008-682X.148069 |
work_keys_str_mv | AT caodehong commentaryoncomparisonoftheefficacyandsafetyofoncedailydosingandondemanduseofudenafilfortype2diabeticpatientswitherectiledysfunction AT liuliangren commentaryoncomparisonoftheefficacyandsafetyofoncedailydosingandondemanduseofudenafilfortype2diabeticpatientswitherectiledysfunction AT weiqiang commentaryoncomparisonoftheefficacyandsafetyofoncedailydosingandondemanduseofudenafilfortype2diabeticpatientswitherectiledysfunction |